Article
How to Read a Next-Generation Sequencing Report for AML and MDS—What Hematologists Need to Know
2025-11-03
Abstract excerpt
Acute myeloid leukemia (AML) and myelodysplastic neoplasms (MDS) are clonal hematopoietic malignancies in which next-generation sequencing (NGS) has become integral for diagnosis, classification, risk stratification, and measurable residual dis-ease (MRD) monitoring. Traditional cytogenetic and PCR-based assays remain useful, but targeted NGS panels now represent the standard of care, providing rapid and sen-sitiv...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 32c4c8c6-b7a2-5487-99d8-b47e13693078
- DOI
- 10.20944/preprints202511.0013.v1
